|
WO2020124274A1
|
|
Modified orthopoxvirus vectors
|
|
WO2020087160A1
|
|
Genetically-engineered mesenchymal stem cells overexpressing aoah and uses thereof
|
|
CA3050645A1
|
|
Treatment of acute myeloid leukemia
|
|
CA3105871A1
|
|
Virtual or augmented reality aided 3d visualization and marking system
|
|
EP3775217A1
|
|
Microrna-based compositions and methods used in disease treatment
|
|
AU2019205037A1
|
|
Modified vaccinia vectors
|
|
KR20200121297A
|
|
Modified Orthopox Virus Vector
|
|
US2020276253A1
|
|
Compositions And Methods for Enhancing Production, Growth, Spread, or Oncolytic and Immunotherapeutic Efficacy of Interferon-Sensitive Viruses
|
|
WO2018195046A1
|
|
A method of stimulating asymmetric division of satellite stem cells
|
|
CN110022889A
|
|
For improving growth, propagation and the oncolytic of oncolytic RNA virus and the composition and method of immunotherapeutic effects
|
|
US2017154422A1
|
|
Method and system for identifying bleeding
|
|
US2017071549A1
|
|
System and method for assisting decisions associated with events relative to withdrawal of life-sustaining therapy using variability measurements
|
|
CA2935649A1
|
|
Treatment of right ventricular dysfunction due to pressure overload
|
|
US2018008673A1
|
|
Treatment of right ventricular dysfunction due to pressure overload
|
|
CA2970954A1
|
|
Compositions and methods for viral sensitization
|
|
WO2015148923A1
|
|
Wnt induced motility and enhanced engraftment of cells
|
|
WO2014198003A1
|
|
Compositions and methods for enhancing virus replication
|
|
WO2014198002A1
|
|
A bacterium producing an interferon binding protein and uses thereof
|
|
WO2014194433A1
|
|
Recombinant oncolytic virus expressing an ifn binding protein
|
|
CA2844895A1
|
|
Adjustable staircase
|
